{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:14:50Z","timestamp":1779236090406,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1124\/molpharm.120.000098","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T23:51:12Z","timestamp":1599781872000},"page":"612-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection"],"prefix":"10.1016","volume":"98","author":[{"given":"Omid","family":"Tavassoly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farinaz","family":"Safavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman","family":"Tavassoly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.120.000098_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jfma.2020.04.013","article-title":"Risk of reactivation or reinfection of novel coronavirus (COVID-19)","volume":"119","author":"Alizargar","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1124\/molpharm.120.000098_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/13506129.2017.1295377","article-title":"A novel murine system for validating the specific targeting of peptides to light chain associated (AL) amyloid","volume":"24","author":"Beierle","year":"2017","journal-title":"Amyloid"},{"key":"10.1124\/molpharm.120.000098_bib3","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1074\/jbc.M114.615401","article-title":"Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans","volume":"290","author":"Blancas-Mej\u00eda","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.120.000098_bib4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/bi101822y","article-title":"Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion","volume":"50","author":"Bourgault","year":"2011","journal-title":"Biochemistry"},{"key":"10.1124\/molpharm.120.000098_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2013.05.038","article-title":"The papillomavirus major capsid protein L1","volume":"445","author":"Buck","year":"2013","journal-title":"Virology"},{"key":"10.1124\/molpharm.120.000098_bib6","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1128\/AAC.02594-14","article-title":"Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures","volume":"58","author":"Cagno","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/molpharm.120.000098_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.matbio.2013.10.004","article-title":"Heparan sulfate proteoglycan as a cell-surface endocytosis receptor","volume":"35","author":"Christianson","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1124\/molpharm.120.000098_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1993.1192","article-title":"Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate","volume":"193","author":"Compton","year":"1993","journal-title":"Virology"},{"key":"10.1124\/molpharm.120.000098_bib9","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"10.1124\/molpharm.120.000098_bib10","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1182\/blood-2007-10-120543","article-title":"Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents","volume":"111","author":"Crowther","year":"2008","journal-title":"Blood"},{"key":"10.1124\/molpharm.120.000098_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00003088-200746070-00002","article-title":"Strategies to improve drug delivery across the blood-brain barrier","volume":"46","author":"de Boer","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/molpharm.120.000098_bib12","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1128\/JVI.00074-08","article-title":"Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation","volume":"82","author":"de Haan","year":"2008","journal-title":"J Virol"},{"key":"10.1124\/molpharm.120.000098_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126239","article-title":"Novel heparan sulfate-binding peptides for blocking herpesvirus entry","volume":"10","author":"Dogra","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.120.000098_bib14","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1128\/AAC.00771-12","article-title":"Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide","volume":"56","author":"Donalisio","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/molpharm.120.000098_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ics.2005.02.022","article-title":"Diphtheria toxin receptor-targeted brain drug delivery","volume":"1277","author":"Gaillard","year":"2005","journal-title":"Int Congr Ser"},{"key":"10.1124\/molpharm.120.000098_bib16","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1096\/fj.201600828R","article-title":"Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation","volume":"31","author":"Gaviglio","year":"2017","journal-title":"FASEB J"},{"key":"10.1124\/molpharm.120.000098_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.antiviral.2016.12.023","article-title":"Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells","volume":"140","author":"Ghezzi","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1124\/molpharm.120.000098_bib18","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.120.000098_bib19","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/JVI.75.3.1565-1570.2001","article-title":"Human papillomavirus infection requires cell surface heparan sulfate","volume":"75","author":"Giroglou","year":"2001","journal-title":"J Virol"},{"key":"10.1124\/molpharm.120.000098_bib20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.cell.2006.02.018","article-title":"A superhighway to virus infection","volume":"124","author":"Greber","year":"2006","journal-title":"Cell"},{"key":"10.1124\/molpharm.120.000098_bib21","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1161\/01.CIR.103.24.2994","article-title":"Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association","volume":"103","author":"Hirsh","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000098_bib22","doi-asserted-by":"crossref","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","article-title":"Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds","volume":"110","author":"Holmes","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.120.000098_bib23","doi-asserted-by":"crossref","first-page":"17062","DOI":"10.1074\/jbc.M500122200","article-title":"Heparan sulfate is a cellular receptor for purified infectious prions","volume":"280","author":"Horonchik","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.120.000098_bib24","doi-asserted-by":"crossref","first-page":"11263","DOI":"10.18632\/aging.103416","article-title":"De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2","volume":"12","author":"Huang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1124\/molpharm.120.000098_bib25","doi-asserted-by":"crossref","first-page":"16543","DOI":"10.1038\/s41598-019-53038-z","article-title":"Contribution of syndecans to cellular uptake and fibrillation of \u03b1-synuclein and tau","volume":"9","author":"Hud\u00e1k","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.120.000098_bib26","doi-asserted-by":"crossref","first-page":"e00586","DOI":"10.1128\/mSphere.00586-18","article-title":"Anticytomegalovirus peptides point to new insights for CMV entry mechanisms and the limitations of in vitro screenings","volume":"4","author":"Jackson","year":"2019","journal-title":"mSphere"},{"key":"10.1124\/molpharm.120.000098_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005318","article-title":"Respiratory syncytial virus uses CX3CR1 as a receptor on primary human airway epithelial cultures","volume":"11","author":"Johnson","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1124\/molpharm.120.000098_bib28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biomaterials.2008.09.042","article-title":"The conjugation of diphtheria toxin T domain to poly(ethylenimine) based vectors for enhanced endosomal escape during gene transfection","volume":"30","author":"Kakimoto","year":"2009","journal-title":"Biomaterials"},{"key":"10.1124\/molpharm.120.000098_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11307-015-0914-9","article-title":"Tc-99m radiolabeled peptide p5\u2009+\u200914 is an effective probe for SPECT imaging of systemic amyloidosis","volume":"18","author":"Kennel","year":"2016","journal-title":"Mol Imaging Biol"},{"key":"10.1124\/molpharm.120.000098_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/13506129.2015.1112782","article-title":"The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice","volume":"23","author":"Kennel","year":"2016","journal-title":"Amyloid"},{"key":"10.1124\/molpharm.120.000098_bib31","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/acs.biochem.6b01056","article-title":"Interaction of Zika virus envelope protein with glycosaminoglycans","volume":"56","author":"Kim","year":"2017","journal-title":"Biochemistry"},{"key":"10.1124\/molpharm.120.000098_bib32","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.4049\/jimmunol.1401902","article-title":"Acidosis increases MHC class II-restricted presentation of a protein endowed with a pH-dependent heparan sulfate-binding ability","volume":"194","author":"Knittel","year":"2015","journal-title":"J Immunol"},{"key":"10.1124\/molpharm.120.000098_bib33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/a-1178-3551","article-title":"Coagulopathy in COVID-19 and its implication for safe and efficacious thromboprophylaxis","volume":"40","author":"Langer","year":"2020","journal-title":"Hamostaseologie"},{"key":"10.1124\/molpharm.120.000098_bib34","first-page":"122","article-title":"Role of glycosaminoglycans for binding and infection of hepatitis B virus","volume":"10","author":"Leistner","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1124\/molpharm.120.000098_bib35","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.1322357111","article-title":"Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.120.000098_bib36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1124\/molpharm.120.000098_bib37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J Exp Med"},{"key":"10.1124\/molpharm.120.000098_bib38","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"Malito","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.120.000098_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bpc.2011.05.011","article-title":"Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction","volume":"158","author":"Martin","year":"2011","journal-title":"Biophys Chem"},{"key":"10.1124\/molpharm.120.000098_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.peptides.2014.07.024","article-title":"Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation","volume":"60","author":"Martin","year":"2014","journal-title":"Peptides"},{"key":"10.1124\/molpharm.120.000098_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2013.05.063","article-title":"Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts","volume":"436","author":"Martin","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/molpharm.120.000098_bib42","doi-asserted-by":"crossref","first-page":"22695","DOI":"10.1038\/srep22695","article-title":"Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis","volume":"6","author":"Martin","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.120.000098_bib43","doi-asserted-by":"crossref","first-page":"13221","DOI":"10.1128\/JVI.02078-14","article-title":"Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells","volume":"88","author":"Milewska","year":"2014","journal-title":"J Virol"},{"key":"10.1124\/molpharm.120.000098_bib44","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180238","article-title":"197 protein used as carrier in conjugate vaccines","volume":"38","author":"Mishra","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1124\/molpharm.120.000098_bib45","doi-asserted-by":"crossref","first-page":"20488","DOI":"10.1038\/srep20488","article-title":"Cross reactive material 197 glycoconjugate vaccines contain privileged conjugation sites","volume":"6","author":"M\u00f6ginger","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.120.000098_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8971036","article-title":"Experimental abdominal sepsis: sticking to an awkward but still useful translational model","volume":"2019","author":"Murando","year":"2019","journal-title":"Mediators Inflamm"},{"key":"10.1124\/molpharm.120.000098_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/prot.20569","article-title":"Docking essential dynamics eigenstructures","volume":"60","author":"Mustard","year":"2005","journal-title":"Proteins"},{"key":"10.1124\/molpharm.120.000098_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40560-017-0270-8","article-title":"The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016)","volume":"6","author":"Nishida","year":"2018","journal-title":"J Intensive Care"},{"key":"10.1124\/molpharm.120.000098_bib49","doi-asserted-by":"crossref","first-page":"25669","DOI":"10.1074\/jbc.M112.363895","article-title":"Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation","volume":"287","author":"Noborn","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.120.000098_bib50","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1073\/pnas.1101194108","article-title":"Heparan sulfate\/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein","volume":"108","author":"Noborn","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.120.000098_bib51","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.5788","article-title":"The COVID-19 pandemic in the US: a clinical update","author":"Omer","year":"2020","journal-title":"JAMA"},{"key":"10.1124\/molpharm.120.000098_bib52","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41577-020-0316-3","article-title":"Will we see protection or reinfection in COVID-19?","volume":"20","author":"Ota","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/molpharm.120.000098_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.antiviral.2016.09.012","article-title":"The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro","volume":"135","author":"Pitt","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1124\/molpharm.120.000098_bib54","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1038\/s41598-018-24904-z","article-title":"Tau internalization is regulated by 6-O sulfation on heparan sulfate proteoglycans (HSPGs)","volume":"8","author":"Rauch","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.120.000098_bib55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/prot.10379","article-title":"Evaluation of protein docking predictions using Hex 3.1 in CAPRI rounds 1 and 2","volume":"52","author":"Ritchie","year":"2003","journal-title":"Proteins"},{"key":"10.1124\/molpharm.120.000098_bib56","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/glycob\/cwp205","article-title":"Heparan sulfate mediates amyloid-beta internalization and cytotoxicity","volume":"20","author":"Sandwall","year":"2010","journal-title":"Glycobiology"},{"key":"10.1124\/molpharm.120.000098_bib57","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/molpharm.120.000098_bib58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2003.10.150","article-title":"Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis","volume":"312","author":"Schonberger","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/molpharm.120.000098_bib59","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","article-title":"Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use","volume":"28","author":"Shinefield","year":"2010","journal-title":"Vaccine"},{"key":"10.1124\/molpharm.120.000098_bib60","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.216259","article-title":"Viral escape from endosomes and host detection at a glance","volume":"131","author":"Staring","year":"2018","journal-title":"J Cell Sci"},{"key":"10.1124\/molpharm.120.000098_bib61","first-page":"3127","article-title":"Time resolved biodistribution of peptide 124I-p5+14 in patients with systemic AL amyloidosis","volume":"61","author":"Stuckey","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1124\/molpharm.120.000098_bib62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2017.04.017","article-title":"Polysulfonate suramin inhibits Zika virus infection","volume":"143","author":"Tan","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1124\/molpharm.120.000098_bib63","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1124\/molpharm.120.000098_bib64","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.jmb.2018.08.002","article-title":"Quinolinic acid amyloid-like fibrillar assemblies seed \u03b1-synuclein aggregation","volume":"430","author":"Tavassoly","year":"2018","journal-title":"J Mol Biol"},{"key":"10.1124\/molpharm.120.000098_bib65","article-title":"Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of \u03b1-synuclein preformed fibrils","author":"Tavassoly","year":"2020","journal-title":"FEBS J"},{"key":"10.1124\/molpharm.120.000098_bib66","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/S2352-3026(20)30151-4","article-title":"COVID-19 coagulopathy: an evolving story","volume":"7","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1124\/molpharm.120.000098_bib67","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jth.13230","article-title":"Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials","volume":"14","author":"Umemura","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1124\/molpharm.120.000098_bib68","doi-asserted-by":"crossref","DOI":"10.1177\/1536012117708705","article-title":"Dual-energy SPECT and the development of peptide p5+14 for imaging amyloidosis","volume":"16","author":"Wall","year":"2017","journal-title":"Mol Imaging"},{"key":"10.1124\/molpharm.120.000098_bib69","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.3390\/molecules20057657","article-title":"Preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis","volume":"20","author":"Wall","year":"2015","journal-title":"Molecules"},{"key":"10.1124\/molpharm.120.000098_bib70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/13506129.2012.757216","article-title":"A novel method for quantifying peripheral tissue amyloid load by using the radiolabeled amyloidophilic peptide, p5","volume":"20","author":"Wall","year":"2013","journal-title":"Amyloid"},{"key":"10.1124\/molpharm.120.000098_bib71","doi-asserted-by":"crossref","first-page":"E586","DOI":"10.1073\/pnas.1103247108","article-title":"In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides","volume":"108","author":"Wall","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.120.000098_bib72","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11307-011-0524-0","article-title":"Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT","volume":"14","author":"Wall","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"10.1124\/molpharm.120.000098_bib73","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2019-128850","article-title":"Preliminary phase 1 data on the safety and efficacy of a novel PET radiotracer, 124I-p5+14, for imaging systemic amyloidosis","volume":"134","author":"Wall","year":"2019","journal-title":"Blood"},{"key":"10.1124\/molpharm.120.000098_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066181","article-title":"A binding-site barrier affects imaging efficiency of high affinity amyloid-reactive peptide radiotracers in vivo","volume":"8","author":"Wall","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.120.000098_bib75","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12031-010-9471-5","article-title":"CRM197-induced blood-brain barrier permeability increase is mediated by upregulation of caveolin-1 protein","volume":"43","author":"Wang","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.1124\/molpharm.120.000098_bib76","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.120.000098_bib77","doi-asserted-by":"crossref","first-page":"10462","DOI":"10.1128\/JVI.00935-12","article-title":"Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network","volume":"86","author":"Xiao","year":"2012","journal-title":"J Virol"},{"key":"10.1124\/molpharm.120.000098_bib78","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1128\/JVI.03647-14","article-title":"Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans","volume":"89","author":"Xu","year":"2015","journal-title":"J Virol"},{"key":"10.1124\/molpharm.120.000098_bib79","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1124\/molpharm.120.000098_bib80","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1124\/molpharm.120.000098_bib81","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1021\/acs.jproteome.0c00129","article-title":"Protein structure and sequence reanalysis of 2019-nCoV genome refutes snakes as its intermediate host and the unique similarity between its spike protein insertions and HIV-1","volume":"19","author":"Zhang","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1124\/molpharm.120.000098_bib82","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/pr.2017.68","article-title":"Heparin-binding EGF-like growth factor promotes neuronal nitric oxide synthase expression and protects the enteric nervous system after necrotizing enterocolitis","volume":"82","author":"Zhou","year":"2017","journal-title":"Pediatr Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24010940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24010940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.120.000098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:36:11Z","timestamp":1739961371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24010940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0026895X24010940"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.120.000098","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.120.000098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}